Search
healthcare › clinical-trials › h-48145
… subcutaneous injections of drug or placebo every four weeks for approximately one year. Eligibility requirements include … BALANCE Study for Patients with Familial Chylomicronemia Syndrome …
news › dr-camp-awarded-1m-for-pancreas-adenocarcinoma-study
… , professor and chief in the Division of Surgical Oncology, has received $1M in funding plus a supply of pembrolizumab … Studies Program. The goal of Dr. Camp’s study, entitled “Phase II Study of Neoadjuvant Folfirinox Chemotherapy …
research › ... › community-engagement-core
… and external stakeholders. The core will develop and adapt best practices to work with residents and local leaders of … to demonstrate cutting-edge identification and remediation practices for PAHs in our target neighborhoods. We will also … investigators and community participants, and disseminate best practices at regional and national levels. The focus …
research › ... › research-support-core
… The Research Support Core will provide a wide range of high … such as metabolomics, epigenomics, and transcriptomics. The RSC leader is Dr. Dean Edwards, executive director of the BCM Advanced Technology Cores. This is a centralized … The Genomic and RNA Profiling Core provides researchers …
news › evenings-with-genetics-new-therapies-for-genetic-conditions
… panel of experts to discuss the newest treatments available for these patients at an upcoming Evenings with Genetics virtual seminar on Tuesday, … gene therapy, along with specific examples of ongoing and completed clinical trials at Baylor/Texas Children’s. A …
healthcare › clinical-trials › h-49814
… at Baylor College of Medicine in collaboration with the University of North Carolina are conducting an international study on obsessive-compulsive disorder (OCD) in Latin American, Hispanic, and … Latin American Trans-Ancestry initiative for OCD Genomics …
healthcare › clinical-trials › h-43993
… Screening for undiagnosed NAFLD and NASH (SUNN study) …
news › a-promising-combination-therapy-for-triple-negative-breast-cancer
… Medicine and collaborating institutions have identified a combination therapy for treating triple-negative breast cancer (TNBC) … TNBC primary tumors and metastasis. The study appeared in the journal Cancer Research . “TNBC is an aggressive … A promising combination therapy for triple-negative breast cancer …
news › a-molecular-glue-for-turning-on-human-cell-pluripotency
… function. These cells maintain the potential to become any of the possible cell types in an organism. … in fields such as regenerative and transplant medicine for their properties, including unlimited self-renewal. The … back into naïve, untrained stem cells. How human NANOG accomplishes this feat remains largely a mystery. Researchers …
about-us › ... › michael-e-debakey-high-school-for-health-professions
… Michael E. DeBakey High School for Health Professions …